Unveiling Decades of Health Records
Researchers at Oregon Health and Science University and the VA Portland Health Care System published a comprehensive investigation on November 16, 2026, examining electronic health records from millions of military veterans. The team analyzed health outcomes for individuals who served during the Vietnam War era, tracking diagnostic records collected between 1999 and 2022. Out of 4.9 million service members screened for the project, the analysis focused on 4,468,509 veterans followed for an average of 12.5 years. The average age of the cohort was 60.6 years, and 98% of the participants were men. By looking at these extensive medical histories, the study aimed to uncover conditions that manifested decades after military service in Southeast Asia.
目录
Military veterans who had documented exposure to Agent Orange demonstrated an overall 57% greater risk of developing Parkinson disease and related neurodegenerative conditions compared to their unexposed peers. To ensure accuracy, the research team adjusted their statistical models for potential confounding health factors, including documented frailty and a history of traumatic brain injury. The findings provide empirical validation for former service members who reported neurological symptoms over multiple decades. Lee Neilson, a neurologist formerly with OHSU and now with the University of Iowa, initiated the project and spoke about the impact on the veteran community.
Veterans have been talking about this for years and years. I expect they will feel validated and heard with this study.
Examining the Scale of Chemical Exposure
Agent Orange was a chemical defoliant used by the American military during the Vietnam War to strip dense jungle canopy and destroy crops, depriving enemy forces of cover and food resources. The tactical herbicide contained a blend of two weedkillers known as 2,4-D and 2,4,5-T, alongside a highly toxic contaminant called dioxin. The U.S. military sprayed the chemical from 1962 to 1975 across vast areas of Southeast Asia. When researchers categorized veterans by exposure levels, they observed varying degrees of elevated risk across the cohort. Veterans with possible or presumed exposure were 44% more likely to be diagnosed with Parkinson disease and 66% more likely to receive a diagnosis of Lewy body dementia relative to service members without chemical exposure. The statistical analysis utilized hazard ratios, which compare how quickly new diagnoses accumulate in exposed versus unexposed groups. For any Agent Orange exposure, the hazard ratio was 1.44 for Parkinson disease and 1.66 for dementia with Lewy bodies.
The risk scaled notably with the intensity of physical contact. Veterans who experienced heavier, direct exposure through the handling and spraying of the chemical defoliant faced a 99% higher likelihood of developing Parkinson disease, yielding a hazard ratio of 1.99. Heightened neurological risks were particularly concentrated among service personnel whose duties involved direct dispersion or handling of the defoliant, specifically members of the Army Chemical Corps and personnel assigned to Operation Air Force Ranch Hand. Gregory Scott, an associate professor of pathology in the OHSU School of Medicine and a pathologist at the VA Portland, served as co-senior author of the study published in the OHSU and VA Portland study in JAMA Neurology.
This is the first study in veterans to identify that increased risk of Parkinson is associated with heavier exposure to Agent Orange. We are catching up with history in a way.
Understanding the Neurological Impact
Parkinson disease and Lewy body dementia are part of a family of disorders known as synucleinopathies, which are defined by abnormal deposits of a misfolded protein called alpha-synuclein. Inside the brain, these clumps build up inside nerve cells and destroy them over time. The study also tracked REM sleep behavior disorder, a condition where the normal muscle paralysis during deep sleep fails and causes individuals to physically act out dreams. Clinicians treat this sleep disorder as an early warning sign of neurodegenerative diseases. Any Agent Orange exposure was associated with a REM sleep behavior disorder hazard ratio of 1.78, while direct or occupational exposure raised that hazard ratio to 2.25. Out of the 4.468 million analyzed records, roughly 7,600 veterans had direct or occupational exposure to the herbicide.
The findings build on earlier scientific investigations into military toxic exposures. A 2021 JAMA Neurology study of 316,351 Vietnam-era veterans found a hazard ratio of 1.68 for dementia, with exposed veterans diagnosed at a younger mean age than unexposed peers. In addition, a 2018 review by the National Academies kept its conclusion of limited or suggestive evidence regarding Parkinson disease, largely because prior studies relied on self-reports or lacked objective measures. Researchers in the new work addressed limitations by accounting for multiple variables, though observational designs cannot definitively prove causation. The authors noted that unknown confounders remain a central limit of retrospective database analyses.
Implications for Federal Policy and Healthcare Access
Shereef Elnahal, president of OHSU and former undersecretary of health in the U.S. Department of Veterans Affairs, highlighted that the research reinforces the rationale behind federal legislation. The PACT Act of 2022 expanded healthcare access for veterans exposed to toxic chemicals, eliminating the individual burden of proof previously required to secure medical coverage. The Department of Veterans Affairs already recognizes Parkinson disease and parkinsonism as presumptive conditions for veterans with qualifying herbicide exposure, allowing eligible individuals to seek disability compensation without proving causation for their specific case. Dr. Elnahal emphasized the personal significance of the findings for former service members.
This research offers critical insight for veterans who may have been diagnosed with Parkinson even decades after their exposure to Agent Orange in Southeast Asia. Veterans who put themselves in harm way deserve to know the truth no matter how long it takes.
Beyond Vietnam, veterans who served in specific locations may also have encountered herbicides and toxic substances. Service members who were stationed in the Korean Demilitarized Zone, on Thai Air Force bases, who flew or worked on C-123 aircraft used for spraying, or who were stationed at testing and storage sites outside Vietnam may qualify for registry exams and benefits. Legislation such as the Blue Water Navy Vietnam Veteran Act of 2019 expanded claims for offshore personnel starting January 1, 2020. Additional regulations introduced in December 2013 recognized Parkinson disease as a secondary condition to service-connected moderate or severe traumatic brain injury.
Chronology of Key Milestones
- 1962 to 1975: The U.S. military sprays Agent Orange across areas of Southeast Asia during the Vietnam War.
- December 2013: The Department of Veterans Affairs recognizes Parkinson disease as a secondary condition to service-connected traumatic brain injury.
- January 1, 2020: The Blue Water Navy Vietnam Veteran Act of 2019 takes effect, allowing offshore navy veterans to apply for exposure claims.
- August 2022: The federal PACT Act is enacted, expanding healthcare benefits and removing the burden of proof for toxic-exposed veterans.
- November 16, 2026: Researchers publish the large-scale electronic health record study in JAMA Neurology.
Broader Lessons for Environmental Health
The implications of the research extend beyond military history and chemical defoliants used decades ago. Gregory Scott noted that the findings should raise awareness about the long-term health risks associated with prolonged exposure to other chemical pesticides and herbicides currently in use. Environmental scientists study how chronic exposure to agricultural chemicals impacts agricultural workers and rural communities over extended periods. Documenting the multi-decade latency period of neurodegenerative diseases demonstrates the importance of early monitoring. Researchers suggest that prompt scientific investigation into modern chemical agents can help prevent future public health crises.
Future scientific work will explore whether veterans exposed to Agent Orange display a distinct clinical picture of Parkinson disease compared to unexposed patients. Some international studies have shown variations in motor symptoms and brain imaging markers, while other prospective U.S. cohorts found minimal clinical differences. As researchers continue to analyze electronic health records and monitor aging veteran populations, medical professionals aim to refine early diagnostic tools. These efforts ensure that affected individuals receive timely clinical support and recognition for service-connected illnesses.
The Bottom Line
- A study of 4.9 million health records found a 57% greater risk of Parkinson disease and related conditions among veterans exposed to Agent Orange.
- Veterans with direct handling or spraying exposure faced a 99% higher likelihood of developing Parkinson disease.
- The research team adjusted their models for traumatic brain injury and frailty to isolate the chemical exposure link.
- Federal legislation like the PACT Act of 2022 removes the burden of proof for veterans seeking medical coverage for presumptive conditions.






